Abiopharma

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

New Form 144 - Perimeter Solutions, Inc. Filed: 2025-09-05 AccNo: 0001950047-25-006777 Size: 4 KB

Martinez Maria E 🟢 acquired 75.0K shares (1 derivative) of Perspective Therapeutics, Inc. (CATX) at $3.38 Transaction Date: Sep 03, 2025 | Filing ID: 113243

New Form 3 - Perspective Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0000950170-25-113242 Size: 20 KB

New Form 144 - BeOne Medicines Ltd. Filed: 2025-09-05 AccNo: 0001950047-25-006771 Size: 4 KB

New Form 3 - OMNICELL, INC. Filed: 2025-09-05 AccNo: 0001415889-25-023785 Size: 9 KB

New Form 424B5 - MUSTANG BIO, INC. Filed: 2025-09-05 AccNo: 0001104659-25-087786 Size: 14 KB

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants